Tulavi Therapeutics, Inc.
MOUNTAIN VIEW, CA · Founded 2018 · CIK 0001738995 · Medtech · Private
Adaptive Hydrogel Technology for nerve repair and neuroma prevention
tulavi.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $13M
- 4 Form D · Dec 2021
- 58 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 25
- 6 granted · 19 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,840,000 | |
| Private capital raised | Form D · SEC | $2,999,999 | |
| Private capital raised | Form D · SEC | $7,499,998 | |
| Private capital raised | Form D · SEC | $1,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 797 | SENSYDIA CORPORATION | — | $16M |
| 798 | I-O Urology Corp | — | $16M |
| 799 | ChemoMouthpiece, LLC | — | $16M |
| 800 | Tulavi Therapeutics, Inc. | — | $13M |
| 801 | MICROVASCULAR TISSUES, INC. | — | $12M |
| 802 | THERAHEART INC. | — | $12M |
| 803 | LADERX LLC | — | $67K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Corinne BrightDirector · Executive Officer
- Tara ButlerDirector
- Greg CasciaroDirector
- Henry ChenDirector
- Farhad KhosraviDirector · Executive Officer
- Amar SawhneyDirector
- Amar SawneyDirector
- Steve WillamsonDirector
Patents
- Methods, Agents, And Devices For Local Neuromodulation Of Autonomic Nervesgranted
- Devices For In Situ Formed, Reinforced Nerve Coaptation Aids, Caps, And Wrapsapplication
- Systems And Methods For Sympathetic Cardiopulmonary Neuromodulationapplication
- Systems And Methods For Gel-based Neuromodulationapplication
- Devices For In Situ Formed, Reinforced Nerve Coaptation Aids, Caps, And Wrapsapplication
- Systems And Methods For Gel-based Neuromodulationapplication
- Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous Systemgranted
- Methods And Compositions For The Ablation Of Nervesapplication
- Methods, Agents, And Devices For Local Neuromodulation Of Autonomic Nervesgranted
- Methods And Devices For Nerve Regenerationapplication
- Systems And Methods For Cardiac Plexus Neuromodulationgranted
- Methods, Agents, And Devices For Local Neuromodulation Of Autonomic Nervesgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.